Colgate-Palmolive (NYSE:CL), a global leader in consumer products, has demonstrated resilience in the face of economic headwinds and market volatility. The company's strong brand portfolio and ...

Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...

Q4 2024 Earnings Call Transcript January 31, 2025 Colgate-Palmolive Company beats earnings expectations. Reported EPS is $0.91, expectations were $0.9. Operator: Good morning. Welcome to today’s ...

Evercore ISI lowered the firm’s price target on Colgate-Palmolive (CL) to $100 from $105 and keeps an Outperform rating on the shares. Shares ...

Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.

Consumer goods manufacturer Colgate-Palmolive (NYSE:CL) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91 ...

Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue milestone in 2024 Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting ...

Colgate announced the re-launch of Colgate Total in 2025, featuring upgraded offerings in toothpaste, manual toothbrushes, and mouthwash. Investments in data, analytics, and AI are expected to support ...

Colgate-Palmolive's adjusted EPS reached $0.91, exceeding analyst expectations of $0.89. Revenue fell slightly short at $4.944 billion compared to the $4.98 billion estimate. The company ...